Dr. David Ahdoot is an accomplished diplomat of the American board of Obstetrics and Gynecology (Ob/Gyn) with offices in Burbank and Palmdale, CA. He is an expert in endometriosis and the clinical speaker of the the new pharmaceutical drug, Orilissa.
Orilissa is the new drug that is indicated for the management of moderate and severe pain associated with endometriosis.
Dr. Ahdoot evaluates patients for endometrioses and provides options for potential surgery and or medical prescription treatments such as Orilissa, at his Burbank and Palmdale, CA locations.
Orilissa, which is the first FDA-approved oral pill specifically developed for women with moderate to severe endometriosis pain in over a decade. It’s a prescription medication available in 2 doses. And, depending on the dose, ORILISSA may reduce 3 common types of endometriosis pain:
Dr. Ahdoot’s next speaking engagement with assigned clinical staff is set for Tuesday, June 25th at Parkway Grill in Pasadena, CA.
